What You Should Know:
– . The first FDA-cleared remote gynecological platform, the Gynescope™, digitally documents the cervix, vagina, and external genitalia. High-quality resolution and superior magnification enhance details beyond the capabilities of traditional cervix exams, enabling more accurate pap smears.
– The funding will enable the company to accelerate its plans to bring cutting-edge gynecological imaging to women across the globe, starting this month with deployments in the United States, United Arab Emirates, India, Singapore, and South Korea. The investment will also support illumigyn’s research and development efforts, which are geared toward turning illumigyn into a comprehensive solution for examining the lower genital tract and providing women across the world the best possible care for cancer and other diseases. This includes the worldwide availability of preventive screenings, evaluations, diagnoses, and treatments.
The Illumigyn Gynescope™ System
As part of its vision to expand access to vital care for women worldwide, illumigyn developed a complete platform featuring the Gynescope™ System, a revolutionary “gynecology endoscope” and cloud platform service with an accompanying mobile application.
The illumigyn Gynescope™ can be handled by any trained caregiver (OB/GYN, GP, Midwife, Nurse Practitioner, and Physician Assistant) so that women of all individual sensitivities can be assessed in a safe space. The HIPAA-compliant solution automatically uploads and securely stores images to the cloud. This allows a doctor or specialist to view the images remotely and provides women with access to their scans and doctors’ recommendations.
“This is another milestone in our vision to democratize women’s healthcare and bring advanced gynecological care to women worldwide,” said Mr. Ran Poliakine, illumigyn’s Founder. “Our deployments this month are aligned with our mission to bring our platform to women everywhere, in developed and developing countries, in population centers, as well as remote communities. This is our mission and our commitment.”